Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
F Martins, L Sofiya, GP Sykiotis, F Lamine… - Nature reviews Clinical …, 2019 - nature.com
Abstract Immune-checkpoint inhibitors (ICIs), including anti-cytotoxic T lymphocyte antigen 4
(CTLA-4), anti-programmed cell death 1 (PD-1) and anti-programmed cell death 1 ligand 1 …
(CTLA-4), anti-programmed cell death 1 (PD-1) and anti-programmed cell death 1 ligand 1 …
Global epidemiology of hyperthyroidism and hypothyroidism
PN Taylor, D Albrecht, A Scholz… - Nature Reviews …, 2018 - nature.com
Thyroid hormones are essential for growth, neuronal development, reproduction and
regulation of energy metabolism. Hypothyroidism and hyperthyroidism are common …
regulation of energy metabolism. Hypothyroidism and hyperthyroidism are common …
[HTML][HTML] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
JR Brahmer, H Abu-Sbeih, PA Ascierto… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …
cancers. While these immunotherapies have improved patient outcomes in many clinical …
[HTML][HTML] Polysaccharide-based nanomedicines for cancer immunotherapy: A review
Cancer immunotherapy is an effective antitumor approach through activating immune
systems to eradicate tumors by immunotherapeutics. However, direct administration of …
systems to eradicate tumors by immunotherapeutics. However, direct administration of …
PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction
Background Antibodies targeting PD-1 and its ligand PDL1 are used in cancer
immunotherapy but may lead to autoimmune diseases, including type 1 diabetes (T1D). It …
immunotherapy but may lead to autoimmune diseases, including type 1 diabetes (T1D). It …
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
S Kimbara, Y Fujiwara, S Iwama, K Ohashi… - Cancer …, 2018 - Wiley Online Library
Thyroid dysfunction (TD) induced by immune checkpoint inhibitors is not sufficiently
understood. The purpose of this retrospective observational study was to identify risk factors …
understood. The purpose of this retrospective observational study was to identify risk factors …
Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
MH Tan, R Iyengar, K Mizokami-Stout, S Yentz… - Clinical diabetes and …, 2019 - Springer
Background Since 2011 six immune checkpoint inhibitors (ICI) have been approved to treat
patients with many advanced solid tumor and hematological malignancies to improve their …
patients with many advanced solid tumor and hematological malignancies to improve their …
French Endocrine Society Guidance on endocrine side effects of immunotherapy
F Castinetti, F Albarel, F Archambeaud… - Endocrine-Related …, 2019 - erc.bioscientifica.com
The management of cancer patients has changed due to the considerably more frequent
use of immune checkpoint inhibitors (ICPIs). However, the use of ICPI has a risk of side …
use of immune checkpoint inhibitors (ICPIs). However, the use of ICPI has a risk of side …
Immune checkpoint inhibitor‐based strategies for synergistic cancer therapy
Immune checkpoint blockade therapy (ICBT) targeting checkpoints, such as, cytotoxic T‐
lymphocyte associated protein‐4 (CTLA‐4), programmed death‐1 (PD‐1), or programmed …
lymphocyte associated protein‐4 (CTLA‐4), programmed death‐1 (PD‐1), or programmed …
Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature
V Lo Preiato, S Salvagni, C Ricci, A Ardizzoni… - Reviews in Endocrine …, 2021 - Springer
Abstract Immune Check-Point Inhibitors (CPIs) have improved long-term patients' outcomes
in several advanced cancers. Diabetes mellitus induced by CPIs (CPI-DM) is considered the …
in several advanced cancers. Diabetes mellitus induced by CPIs (CPI-DM) is considered the …